Loading...
XASX
AVR
Market cap115mUSD
Jul 23, Last price  
4.96AUD
1D
-5.21%
1Q
0.61%
Jan 2017
-86.36%
IPO
-96.98%
Name

Anteris Technologies Ltd

Chart & Performance

D1W1MN
P/E
P/S
40.96
EPS
Div Yield, %
Shrs. gr., 5y
7.95%
Rev. gr., 5y
-23.87%
Revenues
4m
+6.23%
000006,749,7166,435,6537,402,9887,900,09510,133,46014,150,52122,324,14522,610,15825,601,09717,075,3837,078,7837,790,9574,590,0474,111,0814,367,237
Net income
-123m
L+83.06%
-1,111,468-2,089,187-1,126,607-1,020,112-1,174,312-1,420,596-9,995,227-1,892,406-6,616,498-25,253,843-24,013,868-12,312,076-17,263,572-24,217,169-5,819,673-15,274,534-22,907,027-44,340,161-67,333,386-123,263,368
CFO
-99m
L+92.38%
-534,480-1,505,904-921,637-994,446-1,239,557-1,470,916-3,535,754-3,697,260-10,644,351-21,496,204-21,940,524-12,467,781-13,252,614-22,205,313-22,867,298-14,373,162-18,809,609-38,995,191-51,432,580-98,947,083
Earnings
Jul 29, 2025

Profile

Anteris Technologies Ltd operates as a structural heart company. It manufactures and sells ADAPT, a regenerative tissue product. The company also engages in the developing of DurAVRTM, a 3D single piece aortic valve for the treatment of aortic stenosis. In addition, it researches and develops regenerative medicines. The company was formerly known as Admedus Limited and changed its name to Anteris Technologies Ltd in May 2020. Anteris Technologies Ltd was incorporated in 1999 and is based in Toowong, Australia.
IPO date
Mar 24, 2004
Employees
Domiciled in
AU
Incorporated in
AU

Valuation

Title
AUD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122017‑062016‑06
Income
Revenues
4,367
6.23%
4,111
-10.43%
4,590
-41.08%
Cost of revenue
130,993
61,069
48,044
Unusual Expense (Income)
NOPBT
(126,626)
(56,957)
(43,454)
NOPBT Margin
Operating Taxes
(187)
(1,404)
Tax Rate
NOPAT
(126,626)
(56,770)
(42,051)
Net income
(123,263)
83.06%
(67,333)
51.86%
(44,340)
93.57%
Dividends
Dividend yield
Proceeds from repurchase of equity
115,727
78,932
31,959
BB yield
-69.09%
-26.41%
-10.42%
Debt
Debt current
1,210
978
757
Long-term debt
3,291
3,688
1,298
Deferred revenue
Other long-term liabilities
1,312
1,859
2,072
Net debt
(109,338)
(26,166)
(11,750)
Cash flow
Cash from operating activities
(98,947)
(51,433)
(38,995)
CAPEX
(3,661)
(3,552)
(2,409)
Cash from investing activities
(3,684)
(3,902)
(1,360)
Cash from financing activities
182,304
72,950
31,364
FCF
(128,265)
(60,080)
(44,071)
Balance
Cash
113,839
30,832
13,805
Long term investments
Excess cash
113,621
30,626
13,576
Stockholders' equity
(464,284)
28,662
13,218
Invested Capital
569,124
4,192
3,478
ROIC
ROCE
EV
Common stock shares outstanding
20,253
15,606
13,818
Price
8.27
-56.81%
19.15
-13.74%
22.20
71.30%
Market cap
167,492
-43.96%
298,853
-2.57%
306,750
71.30%
EV
58,026
272,747
295,000
EBITDA
(126,626)
(54,167)
(41,712)
EV/EBITDA
Interest
430
967
Interest/NOPBT